Medigene Receives Milestone Payment from Regeneron Pharmaceuticals, Inc.
Portfolio Pulse from
Medigene AG received a $1 million milestone payment from Regeneron Pharmaceuticals, Inc. This payment was triggered by a development milestone in a trial in China for Regeneron's MAGE-A4 cell therapy, which uses a Medigene-generated T cell receptor.
December 03, 2024 | 10:15 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Regeneron Pharmaceuticals made a $1 million milestone payment to Medigene AG for a development milestone in their MAGE-A4 cell therapy trial in China.
The milestone payment indicates progress in Regeneron's MAGE-A4 cell therapy, which could enhance Regeneron's oncology pipeline and investor confidence.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80